WASHINGTON, Jan. 29 -- The U.S. Department of Justice's Drug Enforcement Administration has issued a notice, published in the Federal Register on Jan. 31, 2022, entitled "Importer of Controlled Substances Application: Mylan Pharmaceuticals Inc.". The notice was issued by Brian S. Besser, Acting Assistant Administrator. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed regist  more